gallium has been researched along with Cystic Fibrosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, L; Frangipani, E; Hijazi, S; Imperi, F; Leoni, L; Pirolo, M; Rampioni, G; Sorrentino, R; Ungaro, F; Visaggio, D; Visca, P | 1 |
| Costabile, G; d'Angelo, I; d'Emmanuele di Villa Bianca, R; Frangipani, E; Miro, A; Mitidieri, E; Provenzano, R; Quaglia, F; Sorrentino, R; Ungaro, F; Visaggio, D; Visca, P | 1 |
| Chappell, HF; Hills, OJ; Poskrobko, Z; Scott, AJ; Smith, J | 1 |
| Angarita-Zapata, V; Belmont-Díaz, J; Cazares, A; Coria-Jiménez, R; García-Contreras, R; Jasso-Chávez, R; López-Jacome, LE; Maeda, T; Sanchez-Torres, V; Tovar-García, A | 1 |
| Aitken, ML; Anderson, GD; Becker, L; Britigan, BE; Caldwell, E; Czyz, DM; Goss, CH; Hornick, DB; Kaneko, Y; Khuu, L; Lechtzin, N; McLean, K; Olakanmi, O; Ravishankar, S; Salipante, SJ; Shuman, HA; Siehnel, RJ; Singh, PK; Teresi, M; Wilhelm, E; Zhou, G | 1 |
| Coria-Jiménez, R; García-Contreras, R; Jasso-Chávez, R; Lira-Silva, E; Maeda, T; Pérez-Eretza, B; Rangel-Vega, A; Wood, TK | 1 |
| Abdalla, MY; Aitken, ML; Britigan, BE; Goss, CH; Singh, PK; Switzer, BL | 1 |
| Coria-Jimenez, R; García-Contreras, R; García-Lara, B; Lee, J; Pérez-Eretza, B; Ramasamy, M; Roldán-Sánchez, JA; Saucedo-Mora, MÁ; Tapia, M; Varela-Guerrero, V | 1 |
| Bernabeu, CN; García-Mendiola, T; Hernández, MJ; Lorenzo, E; Marín, AG; Pariente, F; Pau, JL; Piqueras, J | 1 |
| Alipour, M; Azghani, AO; Halwani, M; Omri, A; Suntres, ZE; Yebio, B | 1 |
1 trial(s) available for gallium and Cystic Fibrosis
| Article | Year |
|---|---|
Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; DNA Transposable Elements; Drug Resistance, Bacterial; Drug Synergism; Gallium; Genes, Bacterial; Humans; Iron; Lung; Macrophages; Mice, Inbred C57BL; Microbial Viability; Middle Aged; Mutagenesis; Mutation; Oxidants; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Young Adult | 2018 |
9 other study(ies) available for gallium and Cystic Fibrosis
| Article | Year |
|---|---|
Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens.
Topics: Cystic Fibrosis; Gallium; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia | 2022 |
Boosting lung accumulation of gallium with inhalable nano-embedded microparticles for the treatment of bacterial pneumonia.
Topics: Animals; Cystic Fibrosis; Gallium; Humans; Lung; Male; Mice; Pneumonia, Bacterial; Rats | 2022 |
A DFT study of the gallium ion-binding capacity of mature Pseudomonas aeruginosa biofilm extracellular polysaccharide.
Topics: Biofilms; Calcium; Cystic Fibrosis; Gallium; Humans; Polysaccharides; Pseudomonas aeruginosa; Siderophores | 2023 |
Characterization of gallium resistance induced in a Pseudomonas aeruginosa cystic fibrosis isolate.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Drug Repositioning; Drug Resistance, Bacterial; Gallium; Humans; Oligopeptides; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine | 2020 |
Gallium induces the production of virulence factors in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Gallium; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2014 |
Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Gallium; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2015 |
Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Drug Resistance, Bacterial; Furans; Gallium; Humans; Metal Nanoparticles; Pancreatic Elastase; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Quorum Sensing; Virulence; Virulence Factors; Zinc Oxide | 2015 |
Gallium plasmonic nanoparticles for label-free DNA and single nucleotide polymorphism sensing.
Topics: Biosensing Techniques; Cystic Fibrosis; DNA; DNA Mutational Analysis; Erythrocytes; Escherichia coli; Gallium; Helicobacter pylori; Humans; Nanoparticles; Polymorphism, Single Nucleotide | 2016 |
Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
Topics: Acyl-Butyrolactones; Agrobacterium tumefaciens; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Cystic Fibrosis; Drug Synergism; Epithelial Cells; Gallium; Gentamicins; Humans; Liposomes; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Trypan Blue | 2008 |